Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""immunization, secondary"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 912
Tytuł:
Longitudinal antibody dynamics after COVID-19 vaccine boosters based on prior infection status and booster doses.
Autorzy:
Matsumoto N; Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. .
Sasaki A; Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Kadowaki T; Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Mitsuhashi T; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
Takao S; Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Yorifuji T; Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 25; Vol. 14 (1), pp. 4564. Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19 Vaccines*
COVID-19*/prevention & control
Immunization, Secondary*
Female ; Humans ; Bayes Theorem ; Prospective Studies ; Antibodies ; Antibodies, Viral
SCR Protocol:
COVID-19 vaccine booster shot
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Variant-adapted COVID-19 booster vaccines.
Autorzy:
Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ellebedy AH; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, MO, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Oct 13; Vol. 382 (6667), pp. 157-159. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/immunology
Immunization, Secondary*
Vaccine Efficacy*
Humans ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology
SCR Protocol:
COVID-19 vaccine booster shot
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients.
Autorzy:
Kawabe M; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Kuroda T; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Yamamoto I; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. .
Kobayashi A; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Ohki Y; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Hayashi A; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Miki J; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Yamada H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Matsuo N; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Tanno Y; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Horino T; Department of Infectious Disease and Infection Control, The Jikei University School of Medicine, Tokyo, Japan.
Ohkido I; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Yamamoto H; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Yokoo T; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 20; Vol. 13 (1), pp. 9976. Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
BNT162 Vaccine*/administration & dosage
COVID-19*/prevention & control
Kidney Transplantation*
Immunization, Secondary*
Humans ; Antibodies, Viral ; East Asian People ; Transplant Recipients
SCR Protocol:
COVID-19 vaccine booster shot
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decision nears for fall coronavirus vaccine.
Autorzy:
Couzin-Frankel J
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 May 26; Vol. 380 (6647), pp. 784. Date of Electronic Publication: 2023 May 25.
Typ publikacji:
Wiadomości
MeSH Terms:
COVID-19 Vaccines*/immunology
SARS-CoV-2*/immunology
Immunogenicity, Vaccine*
Immunization, Secondary*
COVID-19*
Humans ; Antibodies, Viral/immunology ; Vaccination
SCR Protocol:
COVID-19 vaccine booster shot
Periodyk
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex.
Autorzy:
Du P; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.
Huang L; Stemirna Therapeutics, Shanghai, China.
Fang Y; Stemirna Therapeutics, Shanghai, China.
Zhao F; Stemirna Therapeutics, Shanghai, China.
Li Q; Stemirna Therapeutics, Shanghai, China.
Ma X; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.
Li R; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.; Medical School, University of Chinese Academy of Sciences, Beijing, China.
Chen Q; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.; Faculty of Health Sciences, University of Macau, Macau, China.
Shen H; Stemirna Therapeutics, Shanghai, China.
Wang Q; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.; Medical School, University of Chinese Academy of Sciences, Beijing, China.; Faculty of Health Sciences, University of Macau, Macau, China.
Li H; Stemirna Therapeutics, Shanghai, China.
Gao GF; CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, China.; Medical School, University of Chinese Academy of Sciences, Beijing, China.; Faculty of Health Sciences, University of Macau, Macau, China.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Apr 01; Vol. 20 (4), pp. e1012116. Date of Electronic Publication: 2024 Apr 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
mRNA Vaccines*
COVID-19*/prevention & control
Animals ; Humans ; Mice ; COVID-19 Vaccines ; Macaca mulatta ; Immunization, Secondary ; Mice, Transgenic ; RNA, Messenger/genetics ; SARS-CoV-2/genetics ; Antibodies, Neutralizing ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Surname order and revaccination intentions during the COVID-19 pandemic.
Autorzy:
Yamamura E; Department of Economics, Seinan Gakuin University, Fukuoka, Japan. .
Tsutsui Y; Faculty of Social Relations, Kyoto Bunkyo University, Kyoto, Japan.
Ohtake F; Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 27; Vol. 14 (1), pp. 4750. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
East Asian People*
Intention*
Names*
Adult ; Female ; Humans ; Male ; COVID-19 Vaccines ; Immunization, Secondary ; Pandemics ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A booster for vaccines from plants.
Autorzy:
Chubatsu Nunes HH; Department of Chemistry, Irving K. Barber Faculty of Science, University of British Columbia, Kelowna, BC, Canada.
Dang TT; Department of Chemistry, Irving K. Barber Faculty of Science, University of British Columbia, Kelowna, BC, Canada.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Mar 24; Vol. 379 (6638), pp. 1187-1188. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Adjuvants, Vaccine*/biosynthesis
Immunization, Secondary*
Quillaja*/metabolism
Saponins*/biosynthesis
Biosynthetic Pathways ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Do COVID-19 vaccine mandates still make sense?
Autorzy:
Vogel G
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Mar 17; Vol. 379 (6637), pp. 1072-1073. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Wiadomości
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*
Health Policy*
Mandatory Programs*
Immunization, Secondary*
Humans ; Trust ; Vaccination
SCR Protocol:
COVID-19 vaccine booster shot
Periodyk
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
New COVID-19 vaccine strategy would mimic flu's annual shots.
Autorzy:
Couzin-Frankel J
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Feb 03; Vol. 379 (6631), pp. 425-426. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Wiadomości
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
Influenza, Human*/prevention & control
Immunization, Secondary*
Humans
SCR Protocol:
COVID-19 vaccine booster shot
Periodyk
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.
Autorzy:
Nash D; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA. .; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA. .; CUNY Graduate School of Public Health and Health Policy, 55 W. 125th St., 6th Floor, New York, NY, 10027, USA. .
Srivastava A; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
Shen Y; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
Penrose K; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
Kulkarni SG; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
Zimba R; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
You W; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
Berry A; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
Mirzayi C; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
Maroko A; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.; Department of Environmental, Occupational, and Geospatial Health Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
Parcesepe AM; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.; Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, USA.; Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Grov C; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.; Department of Community Health and Social Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, NY, USA.
Robertson MM; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, NY, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 644. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
Vaccines*
Adult ; Child ; Humans ; Prospective Studies ; SARS-CoV-2 ; Immunization, Secondary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stochastic dynamical analysis for the complex infectious disease model driven by multisource noises.
Autorzy:
Jian L; The Blood Center of Ningxia Hui Autonomous Region, Yinchuan, China.
Bai X; School of Mathematics and Information Science, North Minzu University, Yinchuan, China.
Ma S; School of Mathematics and Information Science, North Minzu University, Yinchuan, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 04; Vol. 19 (1), pp. e0296183. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Communicable Diseases*
Humans ; Stochastic Processes ; Computer Simulation ; Immunization, Secondary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sequential Immunizations with Influenza Neuraminidase Protein Followed by Peptide Nanoclusters Induce Heterologous Protection.
Autorzy:
Song WW; Hunan Provincial Key Laboratory of Medical Virology, College of Biology, Hunan University, Changsha 410082, China.
Wan MY; Hunan Provincial Key Laboratory of Medical Virology, College of Biology, Hunan University, Changsha 410082, China.
She JY; Hunan Provincial Key Laboratory of Medical Virology, College of Biology, Hunan University, Changsha 410082, China.
Zhao SL; Hunan Provincial Key Laboratory of Medical Virology, College of Biology, Hunan University, Changsha 410082, China.
Liu DJ; Hunan Provincial Key Laboratory of Medical Virology, College of Biology, Hunan University, Changsha 410082, China.
Chang HY; College of Life Sciences, Hunan Normal University, Changsha 410082, China.
Deng L; Hunan Provincial Key Laboratory of Medical Virology, College of Biology, Hunan University, Changsha 410082, China.; Beijing Weimiao Biotechnology Co., Ltd., Haidian District, Beijing 100093, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Jan 03; Vol. 16 (1). Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Neuraminidase*
Influenza, Human*/prevention & control
Animals ; Mice ; Humans ; Influenza A Virus, H3N2 Subtype ; Peptides ; Immunization, Secondary ; Antibodies ; Mice, Inbred BALB C
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study.
Autorzy:
Ab Rahman N; Institute for Clinical Research, National Institutes of Health, Block B4, No 1, Jalan Setia Murni U13/52, 40170, Shah Alam, Selangor, Malaysia. .
Lim MT; Institute for Clinical Research, National Institutes of Health, Block B4, No 1, Jalan Setia Murni U13/52, 40170, Shah Alam, Selangor, Malaysia.
Lee FY; Clinical Research Centre, Selayang Hospital, Ministry of Health, Kepong, Selangor, Malaysia.
Wo WK; National Pharmaceutical Regulatory Agency, Ministry of Health, Shah Alam, Selangor, Malaysia.
Yeoh HS; National Pharmaceutical Regulatory Agency, Ministry of Health, Shah Alam, Selangor, Malaysia.
Peariasamy KM; Institute for Clinical Research, National Institutes of Health, Block B4, No 1, Jalan Setia Murni U13/52, 40170, Shah Alam, Selangor, Malaysia.
Sivasampu S; Institute for Clinical Research, National Institutes of Health, Block B4, No 1, Jalan Setia Murni U13/52, 40170, Shah Alam, Selangor, Malaysia.
Pokaż więcej
Corporate Authors:
SAFECOVAC Study Group
Źródło:
Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20471. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Thrombocytopenia*/chemically induced
Thrombocytopenia*/epidemiology
Venous Thromboembolism*/chemically induced
Venous Thromboembolism*/epidemiology
Humans ; BNT162 Vaccine ; Research Design ; SARS-CoV-2 ; Vaccination/adverse effects ; Malaysia ; Immunization, Secondary/adverse effects
SCR Protocol:
COVID-19 vaccine booster shot
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Antibody response to inactivated COVID-19 vaccine in patients with type 2 diabetes mellitus after the booster immunization.
Autorzy:
Li H; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Wang Y; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Li X; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Wang S; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Feng X; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Xiao X; Department of Endocrinology, Peking Union Medical College Hospital, Beijing, China.
Li Y; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Journal of diabetes [J Diabetes] 2023 Nov; Vol. 15 (11), pp. 931-943. Date of Electronic Publication: 2023 Jul 30.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
COVID-19*/prevention & control
Humans ; COVID-19 Vaccines ; Antibody Formation ; Immunization, Secondary ; SARS-CoV-2 ; Immunoglobulin G
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Heart risks fuel debate over COVID-19 boosters.
Autorzy:
Couzin-Frankel J
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Oct 21; Vol. 378 (6617), pp. 234-235. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Wiadomości
MeSH Terms:
COVID-19*/prevention & control
Immunization, Secondary*/adverse effects
COVID-19 Vaccines*
Myocarditis*/epidemiology
Myocarditis*/etiology
Adolescent ; Humans ; Young Adult ; Adult ; United States
Periodyk
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
New Omicron strains may portend big COVID-19 waves.
Autorzy:
Vogel G
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Sep 30; Vol. 377 (6614), pp. 1479. Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Wiadomości
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19*/virology
COVID-19 Vaccines*/immunology
Immune Evasion*/genetics
Immunization, Secondary*
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
SARS-CoV-2*/pathogenicity
Humans ; Mutation
SCR Protocol:
COVID-19 vaccine booster shot
Periodyk
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
Autorzy:
Lim DS
Choe YJ
Man Kim Y
Lee SE
Jang EJ
Kim J
Park YJ
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2022 Aug; Vol. 28 (8), pp. 1731-1734. Date of Electronic Publication: 2022 Jul 07.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
Immunization, Secondary*/statistics & numerical data
SARS-CoV-2*
Humans ; Incidence ; Republic of Korea/epidemiology ; Vaccination/statistics & numerical data
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
Autorzy:
Hause AM
Baggs J
Marquez P
Abara WE
Baumblatt JG
Thompson D
Su JR
Myers TR
Gee J
Shimabukuro TT
Shay DK
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Jul 15; Vol. 71 (28), pp. 899-903. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Immunization, Secondary*
Adverse Drug Reaction Reporting Systems ; Humans ; United States/epidemiology ; Vaccines, Synthetic ; mRNA Vaccines
SCR Protocol:
COVID-19 vaccine booster shot
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure.
Autorzy:
Reynolds CJ; Department of Infectious Disease, Imperial College London, London, UK.
Pade C; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Gibbons JM; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Otter AD; UK Health Security Agency, Porton Down, UK.
Lin KM; Department of Infectious Disease, Imperial College London, London, UK.
Muñoz Sandoval D; Department of Infectious Disease, Imperial College London, London, UK.
Pieper FP; Department of Infectious Disease, Imperial College London, London, UK.
Butler DK; Department of Infectious Disease, Imperial College London, London, UK.
Liu S; Department of Infectious Disease, Imperial College London, London, UK.
Joy G; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Forooghi N; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Treibel TA; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Institute of Cardiovascular Science, University College London, London, UK.
Manisty C; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Institute of Cardiovascular Science, University College London, London, UK.
Moon JC; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Institute of Cardiovascular Science, University College London, London, UK.
Semper A; UK Health Security Agency, Porton Down, UK.
Brooks T; UK Health Security Agency, Porton Down, UK.
McKnight Á; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Altmann DM; Department of Immunology and Inflammation, Imperial College London, London, UK.
Boyton RJ; Department of Infectious Disease, Imperial College London, London, UK.; Lung Division, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Abbass H
Abiodun A
Alfarih M
Alldis Z
Altmann DM
Amin OE
Andiapen M
Artico J
Augusto JB
Baca GL
Bailey SNL
Bhuva AN
Boulter A
Bowles R
Boyton RJ
Bracken OV
O'Brien B
Brooks T
Bullock N
Butler DK
Captur G
Carr O
Champion N
Chan C
Chandran A
Coleman T
Couto de Sousa J
Couto-Parada X
Cross E
Cutino-Moguel T
D'Arcangelo S
Davies RH
Douglas B
Di Genova C
Dieobi-Anene K
Diniz MO
Ellis A
Feehan K
Finlay M
Fontana M
Forooghi N
Francis S
Gibbons JM
Gillespie D
Gilroy D
Hamblin M
Harker G
Hemingway G
Hewson J
Heywood W
Hickling LM
Hicks B
Hingorani AD
Howes L
Itua I
Jardim V
Lee WJ
Jensen M
Jones J
Jones M
Joy G
Kapil V
Kelly C
Kurdi H
Lambourne J
Lin KM
Liu S
Lloyd A
Louth S
Maini MK
Mandadapu V
Manisty C
McKnight Á
Menacho K
Mfuko C
Mills K
Millward S
Mitchelmore O
Moon C
Moon J
Muñoz Sandoval D
Murray SM
Noursadeghi M
Otter A
Pade C
Palma S
Parker R
Patel K
Pawarova M
Petersen SE
Piniera B
Pieper FP
Rannigan L
Rapala A
Reynolds CJ
Richards A
Robathan M
Rosenheim J
Rowe C
Royds M
Sackville West J
Sambile G
Schmidt NM
Selman H
Semper A
Seraphim A
Simion M
Smit A
Sugimoto M
Swadling L
Taylor S
Temperton N
Thomas S
Thornton GD
Treibel TA
Tucker A
Varghese A
Veerapen J
Vijayakumar M
Warner T
Welch S
White H
Wodehouse T
Wynne L
Zahedi D
Chain B
Moon JC
Pokaż więcej
Corporate Authors:
COVIDsortium Investigators§
COVIDsortium Immune Correlates Network§
Źródło:
Science (New York, N.Y.) [Science] 2022 Jul 15; Vol. 377 (6603), pp. eabq1841. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
B-Lymphocytes*/immunology
BNT162 Vaccine*/immunology
BNT162 Vaccine*/therapeutic use
COVID-19*/immunology
COVID-19*/prevention & control
Immunization, Secondary*
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
T-Lymphocytes*/immunology
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Cross Reactions ; Humans ; Mice ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Billions boost next-generation weapons against SARS-CoV-2.
Autorzy:
Cohen J
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Oct 27; Vol. 382 (6669), pp. 359-360. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Wiadomości
MeSH Terms:
Antibodies, Monoclonal*/administration & dosage
COVID-19*/prevention & control
SARS-CoV-2*
COVID-19 Vaccines*/administration & dosage
Humans ; Antibodies, Neutralizing/administration & dosage ; Antibodies, Viral/administration & dosage ; Government ; Administration, Intranasal ; United States Government Agencies ; United States ; Immunization, Secondary
SCR Protocol:
COVID-19 vaccine booster shot
Periodyk
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 912

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies